· 18/11/2020
Phase I/IIa study in subjects with Retinitis Pigmentosa
· 18/11/2020Recruiting
KODIAK: A phase II study in patients with the exudative form of AMD
· 18/11/2020Recruiting
REVERS: Study using postbiotics in AMD patients
· 18/11/2020Recruiting
ISEE2008: Phase III clinical trial in patients with dry AMD
· 14/02/2020
Clinical trial OAKS-DERBY: efficacy and safety of APL-2 in the treatment of geographic atrophy secondary to AMD
· 26/11/2019Recruiting
TALON clinical trial: Efficacy and safety of brolacizumab in the treatment of exudative AMD
· 13/11/2019Recruiting
Research project MICROBEYEOME
· 09/04/2019
LUCERNE clinical trial: efficacy and safety of FARICIMAB regarding aflibercept in the treatment of exudative age-related macular degeneration
· 03/03/2019
RHINE – Phase III study in the treatment of diabetic macular oedema
· 03/10/2018
Clinical trial THR-317-002: Efficacy and safety of THR-317 with ranibizumab in the treatment of diabetic macular oedema
· 03/10/2018
Clinical Trial KESTREL: Efficacy and safety of brolucizumab in comparison with aflibercept in diabetic macular edema
· 10/05/2018
Clinical trial OPH2005: Efficacy and safety of Zimura in the treatment of Stargardt’s disease
· 31/03/2016
Proxima A: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29633)
· 31/03/2016
Proxima B: Epidemiological study of the progression of Geographic Atrophy secondary to Age-Related Macular Degeneration (GX29639)
· 21/09/2015
HARRIER: Clinical trial on patients with choroidal neovascularisation secondary to AMD